WFSBP 2021 Preliminary Program

WFSBP 2021 9 Wednesday, 30 June 2021 / Preliminary Scientific Program Schedule 7:30 S-36 The genomics of severe depression and ECT S-37 Electroconvulsive therapy in Austria S-38 Minocycline in psychiatry ES-04 Understanding and performing meta- analysis S-40 Involvement of the immune system in schizophrenia, depression and anxiety disorders S-41 Neurotrophins and their role in anti- depressive therapy 8:00 8:30 9:00 9:30 Plenary Lecture PL-03 Cannabis: the good, the bad, and the mad (Robin Murray, United Kingdom) 10:00 10:30 11:00 D-03 Are psychedelic drugs useful in the treatment of psychiatric disorders? S-42 Drug level monitoring with a focus on perina- tal disorders: Clinical and research dilemmas S-43 Staging of psychosis: Vision and challenges S-44 Metabolic perspective on neurocognition and illness progression in Bipolar Disorder S-45 Appetite regulating peptides – an innova- tive neuroendocrino- logical therapy strategy for relapse prevention and craving in patients suffering from alcohol use disorder and tobac- co dependence? 11:00–12:30 S-46 Computerized proce- dures supporting diag- nostics in psychiatry: using AI to develop novel biomarker and diagnostic tool for psychiatric research and clinical practice 11:00–12:30 11:30 12:00 12:30 13:00 Satellite Symposia 13:30 14:00 14:30 15:00 S-47 hiPSC technology: new approaches to dissect the molecular genetic mechanisms underlying schizophrenia S-48 The complex inter- relationships between therapeutic interven- tions, neuroanatomy, and cognition in major psychosis S-49 Recognizing and treat- ing non-classical forms of Bipolar Disorder TFS-06 Stress and suicide in men in the COVID-19 era S-50 Electroconvulsive Therapy beyond depression: specific populations and (yet) rare indications ES-05 Understanding and designing imaging studies 15:30 16:00 16:30 17:00 Plenary Lecture PL-04 Stem cells in mental disorders: new understanding and treatment (Kristen Brennand, USA) 17:30 18:00 18:30 S-51 Behavioral addictions: Brain imaging findings and their translation to clinical practice S-52 Biomarkers of response to IV Ketamine for depression TFS-07 Violence and men: Recent research and clinical aspects S-53 Chronobiology: from basic concepts to clinical practice in mood disorders S-54 Benefit of Ketamine in clinical practice: Current perspectives S-55 The present and future of biological psychiatry through the eyes of residents 19:00 19:30 20:00 20:30 All sessions run in Central European Summer Time (CEST). Virtual Posters accessible all day